Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06018194

ELUCIDATE FFRct Study

Sponsor: Elucid Bioimaging Inc.

View on ClinicalTrials.gov

Summary

The goal of this study is to evaluate the diagnostic accuracy of a novel plaque-based coronary CT angiography (CCTA) fractional flow reserve (FFRct) software device for the estimation of invasive fractional flow reserve (FFR). Researchers will compare the Elucid plaque-based FFRct analysis to invasively measured FFR in patients who have previously undergone CCTA and invasively assessed FFR.

Official title: The ELUCIDATE FFRct Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

439

Start Date

2023-09-01

Completion Date

2025-07-28

Last Updated

2026-09-08

Healthy Volunteers

No

Interventions

DEVICE

ElucidVivo

Plaque morphology characterization on coronary CTA for predicting fractional flow reserve (FFRct)

Locations (7)

Cardiovascular Medical Group of Southern California

Beverly Hills, California, United States

Piedmont Healthcare

Atlanta, Georgia, United States

Parkview Health

Fort Wayne, Indiana, United States

Midwest Heart and Vascular Specialists

Overland Park, Kansas, United States

Valley Health System

Ridgewood, New Jersey, United States

Ascension Medical Group

Nashville, Tennessee, United States

University of Virginia

Charlottesville, Virginia, United States